InTandem Capital Partners

What InTandem Capital Partners does

InTandem Capital Partners, LLC is a New York-based private equity firm founded in 2011 that invests exclusively in lower middle-market healthcare services companies in the United States. The firm pursues control investments across four healthcare verticals — payor and employer services, provider and care delivery, healthcare technology services, and pharmaceutical services — using a 'Buy and Build' strategy to consolidate regional providers into national platforms. InTandem has raised two healthcare services buyout funds totaling $425 million in LP commitments (Fund I: $175M in 2017; Fund II: $250M in 2019) from institutional investors including endowments, foundations, family offices, and outsourced CIO firms.

The firm differentiates itself through an operationally intensive model built around an integrated team of Investment Partners and Operating Partners, many of whom are former healthcare CEOs and executives (including ex-prodigy Health Group, Intuit, eBay, McKinsey, ICON, Anthem, and Optum alumni). Its portfolio currently spans more than a dozen active platforms across dental support (beBright, Paradigm Oral Health), oral surgery, fertility (Ivy Fertility), infusion (Vivo Infusion), home care (HouseWorks, Pediatric Home Service), hospice (Providence Care), behavioral health (Turning Point Centers), musculoskeletal care (Sequel Ortho, OrthoNebraska), revenue cycle management (Healthfuse), cost containment (The Phia Group), and CNS clinical research (Clinilabs, Adams Clinical), plus realized investments such as Cano Health (taken public via SPAC in 2020).

InTandem generates revenue through traditional private equity fund economics — management fees on committed or invested capital (typically 1.5–2.0%) plus carried interest on realized gains above a hurdle rate — supplemented by operational support fees across portfolio companies. The firm's go-to-market relies on proprietary deal sourcing through its operating-team network, healthcare industry conferences, investment banking relationships, and referrals from portfolio-company management teams. In 2022, the firm launched the PE4GG (Private Equity for Greater Good) initiative, committing portfolio companies to broad-based employee participation in investment gains, which functions as both a differentiator for management teams and a brand-positioning lever for LP fundraising.

Name

InTandem Capital Partners

Legal name

InTandem Capital Partners, LLC

Website

http://www.intandemcapital.com/

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

InTandem Capital Partners is a New York-based private equity firm founded in 2011 that makes control investments in lower middle-market U.S. healthcare services companies across payor, provider, technology, and pharmaceutical services verticals, deploying $425 million across two buyout funds.

Ownership category

akta.pro rank

Product category

Private Equity — Healthcare Services

NAICS

Portfolio Management and Investment Advice (523940), All Other Financial Investment Activities (52399), Funds, Trusts, and Other Financial Vehicles (525)

SIC

Investment Advice (6282)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

akta.pro secondary industries

Institutional Capital Introduction (LP/Family Office/Endowment Matching) (FSAEALAI), Equity Capital Advisory (Private Equity Placements, Growth Capital) (BPAHAOAE)

Keywords

• Private equity investment
• Healthcare services investing
• Buyout fund management
• Lower middle market
• Portfolio company operations

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Fund Management: InTandem Capital Partners generates revenue through traditional private equity fund economics including management fees (typically 1.5-2% on committed capital) and carried interest (typically 20% of profits above the hurdle rate). The firm has raised two healthcare services buyout funds totaling $425 million in LP commitments.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

InTandem Capital Partners is a private equity firm that makes control investments in small to mid-sized companies operating in select healthcare services sectors. The firm operates two buyout funds with $425 million in combined limited partner commitments and pursues an operationally intensive approach through an integrated operating team of former healthcare executives to help portfolio companies scale into national platforms.

Product overview

InTandem Capital Partners operates as a private equity firm that invests in and accelerates the growth of small to mid-sized companies in select healthcare services sectors. Rather than a unified software product, the firm offers an operationally intensive investment approach utilizing an integrated operating team to help healthcare services companies scale. The firm's portfolio spans multiple healthcare verticals including dental services (beBright, Paradigm Oral Health), clinical research (Clinilabs, Adams Clinical), revenue cycle management (Healthfuse, The Phia Group), home care (HouseWorks, Pediatric Home Service), infusion services (Vivo Infusion), fertility (Ivy Fertility), behavioral health (Turning Point Centers), post-acute care (Providence Care), musculoskeletal care (Sequel Ortho), and primary care for seniors (Cano Health - realized). The firm provides strategic, acquisition, and operating expertise to portfolio companies through active support and an industry executive network.

Differentiator

Problem solved

Functional benefit

Products and services

• InTandem Capital Partners Fund, LP (Fund I) A private equity buyout fund vehicle that accepts limited partner commitments from institutional investors to make control investments in healthcare services companies using a Buy and Build approach.
• InTandem Capital Partners Fund II, LP A second private equity buyout fund vehicle accepting limited partner commitments to make control investments in select healthcare services companies using an operationally intensive approach to accelerate growth and create value.
• Operational and Investment Partnership Services An operationally intensive investment partnership service for healthcare services companies that delivers strategic, acquisition, operating, and leadership development expertise alongside capital, leveraging an integrated operating team of former healthcare executives to help local leaders become national powerhouses.

Quantifiable outcome

• Cano Health achieved 14,000% three-year revenue growth, ranking #1 fastest-growing healthcare company on Inc. 5000 in 2019
• +2 more outcomes

Named customers12 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered minor and core.

• Provident Healthcare PartnersminorChannel Partner/ Reseller/ Distributor · 11 March 2026Provident Healthcare Partners advised A Caring Experience Nursing Services on its acquisition by HouseWorks Holdings, LLC, a portfolio company of InTandem Capital Partners.
• Physician Growth PartnersminorChannel Partner/ Reseller/ Distributor · 10 November 2025Physician Growth Partners advised Fox Valley Orthopedics on its strategic partnership with Sequel Ortho, an InTandem Capital Partners portfolio company.
• SA Global AdvisorsminorStrategic or Co-development Partner · 13 June 2025SA Global Advisors published market analysis documenting InTandem Capital Partners' investment in Healthfuse as part of broader M&A activity in the healthcare revenue cycle management sector.
• Private Equity for Greater Good (PE4GG)coreStrategic or Co-development Partner · 1 January 2022PE4GG was launched by InTandem Capital Partners as a national initiative that commits PE firms to distributing a portion of investment gains to all employees of portfolio companies, not just senior executives. The initiative aims to shift norms of employee equity participation in private equity-backed companies and was launched as an industry-wide effort.

Scale indicators3 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Webster Equity Partners: Boston-based healthcare services-focused private equity firm making control investments in lower middle-market healthcare companies — directly comparable to InTandem in vertical focus, fund size, and operating-partner approach.
• Linden Capital Partners: Chicago-based private equity firm exclusively dedicated to healthcare, making control investments in middle-market healthcare services and products companies — overlapping focus area with InTandem's healthcare services mandate.
• Frazier Healthcare Partners: Seattle-based healthcare-only PE firm with both growth and buyout strategies covering services, pharma, and medtech — comparable to InTandem in healthcare specialization and lower middle-market focus.
• Sheridan Capital Partners: Chicago-based private equity firm focused exclusively on healthcare services buyouts in the lower middle market — the closest peer to InTandem by mandate, fund size, and operating approach; InTandem's controller previously worked at Sheridan.
• Avista Capital Partners: New York-based healthcare-focused private equity firm investing in middle-market healthcare services, pharma services, and medical technology — comparable to InTandem in sector focus and US lower middle-market focus.
• One Equity Partners: Middle-market private equity firm with a significant healthcare practice; InTandem President Brad Coppens was previously Senior Managing Director there focused on healthcare for 15+ years — making OEP a directly comparable peer.
• Arsenal Capital Partners: New York-based middle-market PE firm with healthcare services, specialty industrials, and financial services focus; InTandem Partner Mehran Ahmed previously worked at Arsenal — comparable to InTandem in mid-market healthcare services investing.

Broad incumbents

• Welsh, Carson, Anderson & Stowe: Large healthcare/technology-focused PE firm — comparable in vertical healthcare specialization but substantially larger AUM and broader stage range than InTandem; serves as an aspirational peer and incumbent in the space.
• Court Square Capital Partners: Middle-market private equity firm with healthcare exposure; InTandem Principal Evan Brower previously worked there — broader industry exposure but overlapping lower middle-market healthcare services deal activity.

Others

• GCA Advisors: Investment bank and placement agent that acted as placement agent for both InTandem Fund I and Fund II — a key service-provider peer in the capital formation ecosystem and indicative of the firm's position in the institutional LP landscape.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/intandem-capital-partners

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A8 records

Investments7 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about InTandem Capital Partners